VEGFC Antibody Therapy Drives Differentiation of AML.
Kampen KR, Scherpen FJG, Mahmud H, Ter Elst A, Mulder AB, Guryev V, Verhagen HJMP, De Keersmaecker K, Smit L, Kornblau SM, De Bont ESJM.
Kampen KR, et al. Among authors: scherpen fjg.
Cancer Res. 2018 Oct 15;78(20):5940-5948. doi: 10.1158/0008-5472.CAN-18-0250. Epub 2018 Sep 5.
Cancer Res. 2018.
PMID: 30185550